Evoke Pharma INC DEF 14A proxy statements

Evoke Pharma will hold its annual stockholders meeting on May 21, 2025, to vote on director elections, auditor ratification, executive compensation, and the frequency of executive compensation votes.

Evoke Pharma announces its 2025 annual stockholders meeting to be held virtually on May 21, 2025, featuring proposals including director elections, auditor ratification, and executive compensation votes.

Evoke Pharma files an amendment to its annual report to restate financial statements due to a classification error related to a note payable to Eversana, impacting interim periods in 2023.

Evoke Pharma's annual stockholders meeting will take place on May 22, 2024, featuring proposals including director elections, auditor ratification, executive compensation, increasing authorized shares, a potential reverse stock split, and amending the equity incentive plan.

Evoke Pharma's upcoming annual meeting will address critical proposals including director elections, auditor ratification, executive compensation, a potential reverse stock split, and an increase in authorized common stock.